Showing results (61-70 of 208) with videos related to
Sort By:
Pageof 21
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 29, 2014
Characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals in Tokyo, JapanHidemasa Nakaminami, Norihisa Noguchi, Ayumu Ito, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 9, 2020
Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophreniaYui Murata, Tempei Ikegame, Shinsuke Koike, et al.Pharmacogenomics|October 16, 2008
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophreniaMasashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, et al.Psychiatry and Clinical Neurosciences|September 14, 2023
Neuropathological substrate of incident dementia in older patients with schizophrenia: A clinicopathological studyShusei Arafuka, Hiroshige Fujishiro, Youta Torii, et al.Neuromolecular Medicine|April 7, 2009
CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patientsTaro Kishi, Tsuyoshi Kitajima, Masashi Ikeda, et al.Schizophrenia Research|March 31, 2009
Meta-analysis of association between genetic variants in COMT and schizophrenia: an updateTomo Okochi, Masashi Ikeda, Taro Kishi, et al.Journal of Human Genetics|August 8, 2020
Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese populationKoya Fukunaga, Eiji Hishinuma, Masahiro Hiratsuka, et al.Neuromolecular Medicine|June 23, 2009
Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese populationTaro Kishi, Tsuyoshi Kitajima, Tomoko Tsunoka, et al.Neuropsychiatric Disease and Treatment|November 8, 2019
Rare compound heterozygous missense <i>SPATA7</i> variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control studyHirofumi Igeta, Yuichiro Watanabe, Ryo Morikawa, et al.Translational Psychiatry|July 7, 2021
Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UKKohei Ninomiya, Takeo Saito, Tomo Okochi, et al.Pageof 21